|
1
|
Dogan N, Dogan I and Toprak D:
Geographıcal distribution and trends of women breast cancer
Mortality in Turkey between 2009-2019. Ankara Med J. (4):366–377.
2023.
|
|
2
|
Global Cancer Observatory: Cancer Today.
International Agency for Research on Cancer, Lyon, 2024.
|
|
3
|
Lan T, Lu Y, He J, Zhan C, Wang X, Shao X
and Hu Z: Global, reginal, national burden and risk factors in
female breast cancer from 1990 to 2021. iScience.
27(111045)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ning C, Yan Y, Wang Y, Li R, Liu W, Qiu L,
Sun L and Yang Y: Research trends on chemotherapy induced nausea
and vomiting: A bibliometric analysis. Front. Pharmacol.
15(1369442)2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Grassi L, Berardi MA, Ruffilli F,
Meggiolaro E, Andritsch E, Sirgo A, Caruso R, Juan Linares E, Bellé
M, Massarenti S, et al: Role of psychosocial variables on
chemotherapy-induced nausea and vomiting and health-related quality
of life among cancer patients: A European study. Psychother
Psychosom. 84:339–347. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Herrstedt J, Clark-Snow R, Ruhlmann CH,
Molassiotis A, Olver I, Rapoport BL, Aapro M, Dennis K, Hesketh PJ,
Navari RM, et al: 2023 MASCC and ESMO guideline update for the
prevention of chemotherapy- and radiotherapy-induced nausea and
vomiting. ESMO Open. 9(102195)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Aapro M: CINV: Still troubling patients
after all these years. Support Care Cancer. 26 (Suppl 1):S5–S9.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sun X, Nie F, Sun J, Zhang J and Wang Y:
Medicinal plants for chemotherapy-induced nausea and vomiting: A
systematic review of antiemetic, chemosensitizing, and
immunomodulatory mechanisms. Ther Clin Risk Manag. 21:1187–1218.
2025.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen W, Zhao Y, Dai Y and Nie K:
Gastrointestinal inflammation plays a critical role in
chemotherapy-induced nausea and vomiting. Eur J Pharmacol.
936(175379)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Navari RM and Aapro M: Antiemetic
prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J
Med. 374:1356–1367. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
He Y, Zheng J, Ye B, Dai Y and Nie K:
Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and
current management. Biochem Pharmacol. 216(115787)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ullah I and Ayaz M: A re-consideration of
neural/receptor mechanisms in chemotherapy-induced nausea and
vomiting: Current scenario and future perspective. Pharmacol Rep.
75:1126–1137. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xie X, Li H, Li Y, Fu H, Wang Y and Cheng
J: Risk prediction models for chemotherapy-induced nausea and
vomiting: A systematic review and meta-analysis. Front Oncol.
16(1750558)2026.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Buonacera A, Stancanelli B, Colaci M and
Malatino L: Neutrophil to lymphocyte ratio: An emerging marker of
the relationships between the immune system and diseases. Int J Mol
Sci. 23(3636)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng
J, Li Y, Wang X and Zhao L: Inflammatory responses and
inflammation-associated diseases in organs. Oncotarget.
9:7204–7218. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Heshmat-Ghahdarijani K, Sarmadi V, Heidari
A, Falahati Marvasti A, Neshat S and Raeisi S: The
neutrophil-to-lymphocyte ratio as a new prognostic factor in
cancers: A narrative review. Front Oncol.
13(1228076)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ethier JL, Desautels D, Templeton A, Shah
PS and Amir E: Prognostic role of neutrophil-to-lymphocyte ratio in
breast cancer: A systematic review and meta-analysis. Breast Cancer
Res. 19(2)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guthrie GJ, Charles KA, Roxburgh CS,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230.
2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106(dju124)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Republic of Türkiye: Personal Data
Protection Law No. 6698. Official Gazette No. 29677, 7 April 2016.
https://www.kvkk.gov.tr/Icerik/6649/Personal-Data-Protection-Law.
|
|
21
|
Karaca O and Dogan G: Can
neutrophil-to-lymphocyte or platelet-to-lymphocyte ratio be used to
predict postoperative nausea and vomiting in breast reduction?
Cureus. 12(e7237)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jiang T, Wang X, Zheng L, Ren T, Li Y and
Li J: Risk factors of nausea and vomiting in patients with breast
cancer undergoing chemotherapy: A retrospective study. Medicine
(Baltimore). 104(e41067)2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Feng Y, Wei L, Zou Q, Lei X and Yang X:
Prevalence and risk factors for nausea and vomiting in breast
cancer patients undergoing chemotherapy. Acta Oncol. 65:252–260.
2026.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Naito Y, Kai Y, Ishikawa T, Fujita T,
Uehara K, Doihara H, Tokunaga S, Shimokawa M, Ito Y and Saeki T:
Chemotherapy-induced nausea and vomiting in patients with breast
cancer: A prospective cohort study. Breast Cancer. 27:122–128.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hu Z, Liang W, Yang Y, Keefe D, Ma Y, Zhao
Y, Xue C, Huang Y, Zhao H, Chen L, et al: Personalized estimate of
chemotherapy-induced nausea and vomiting: Development and external
validation of a nomogram in cancer patients receiving
highly/moderately emetogenic chemotherapy. Medicine (Baltimore).
95(e2476)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang J: Factors affecting
chemotherapy-induced nausea and vomiting in patients with lung
squamous cell carcinoma. Am J Transl Res. 17:5129–5140.
2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alemohammad SS, Mahaseni Aghdam H,
Mesgarzadeh V, Ardalani R, Farahmand M and Shalalvand M: Evaluation
of the relationship between preoperative neutrophil-to-lymphocyte
ratio and platelet-to-lymphocyte ratio and postoperative nausea and
vomiting in rhinoplasty surgery. Indian J Otolaryngol Head Neck
Surg. 77:2117–2122. 2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pirri C, Bayliss E, Trotter J, Olver IN,
Katris P, Drummond P and Bennett R: Nausea still the poor relation
in antiemetic therapy? The impact on cancer patients' quality of
life and psychological adjustment of nausea, vomiting and appetite
loss, individually and concurrently as part of a symptom cluster.
Support Care Cancer. 21:735–748. 2013.PubMed/NCBI View Article : Google Scholar
|
